The B-Raf V600E mutant, found in 65% of human melanomas, drives constitutive activation of the extracellular signal-regulated kinase (ERK) pathway and is implicated in tumorigenesis. Recently, we showed that B-Raf is important for spindle formation and the mitotic spindle checkpoint arrest. In this study, we demonstrate that B-Raf V600E signaling deregulates the spindle checkpoint as a consequence of stabilizing monopolar spindle 1 (Mps1) levels in human melanoma cells. Upon introducing the B-Raf V600E mutant into wild-type B-Raf melanoma cells, Mps1 protein and activity increased 3-and 10-fold, respectively. In addition, Mps1 became hyperphosphorylated, which correlated with stabilization of Mps1 protein levels. In contrast, reduction of B-Raf by RNAi or inactivation of ERK by the MEK inhibitor U0126 resulted in a precipitous decline in Mps1 levels. Together, these results suggest that B-Raf signaling through ERK regulates the stability of Mps1. Finally, B-Raf V600E expression induces a mitotic delay due to promoting robust activation of the mitotic spindle checkpoint. These effects were dependent on the induction of Mps1 levels by oncogenic B-Raf V600E as shown by depleting Mps1 with short interfering RNA. Collectively, our findings implicate a new mechanism through which B-Raf V600E exerts its oncogenic effects in melanoma.
The B-Raf V600E mutant, found in 65% of human melanomas, drives constitutive activation of the extracellular signal-regulated kinase (ERK) pathway and is implicated in tumorigenesis. Recently, we showed that B-Raf is important for spindle formation and the mitotic spindle checkpoint arrest. In this study, we demonstrate that B-Raf V600E signaling deregulates the spindle checkpoint as a consequence of stabilizing monopolar spindle 1 (Mps1) levels in human melanoma cells. Upon introducing the B-Raf V600E mutant into wild-type B-Raf melanoma cells, Mps1 protein and activity increased 3-and 10-fold, respectively. In addition, Mps1 became hyperphosphorylated, which correlated with stabilization of Mps1 protein levels. In contrast, reduction of B-Raf by RNAi or inactivation of ERK by the MEK inhibitor U0126 resulted in a precipitous decline in Mps1 levels. Together, these results suggest that B-Raf signaling through ERK regulates the stability of Mps1. Finally, B-Raf V600E expression induces a mitotic delay due to promoting robust activation of the mitotic spindle checkpoint. These effects were dependent on the induction of Mps1 levels by oncogenic B-Raf V600E as shown by depleting Mps1 with short interfering RNA. Collectively, our findings implicate a new mechanism through which B-Raf V600E exerts its oncogenic effects in melanoma.
Introduction
Raf kinases (A-Raf, B-Raf and C-Raf) stimulate the MAP kinase-signaling cascade, which consists of MEK and extracellular signal-regulated kinase (ERK). In addition to its established roles in promoting cell cycle entry and progression through the G 1 /S transition, the MAP kinase cascade regulates later parts of the cell cycle, including the G 2 /M transition (Wright et al., 1999; Liu et al., 2004) , mitotic spindle formation (Horne and Guadagno, 2003) and maintenance of the spindle assembly checkpoint arrest (Takenaka et al., 1997; Wang et al., 1997) . Previously, we demonstrated that the B-Raf isoform mediates mitotic activation of the MAP kinase pathway in Xenopus egg extracts (Borysov et al., 2006) . Follow-up studies in human somatic cells revealed that depletion of B-Raf severely impairs spindle formation, chromosome congression and spindle checkpoint activation (Borysova et al., manuscript submitted). Thus, the B-Raf/MEK/ERK cascade appears to have cell cycle roles that extend to critical functions during mitosis.
Activating point mutations in the B-RAF gene are observed in a variety of human cancers, most notably in 60-70% of cutaneous melanomas Kumar et al., 2003) , 35-60% papillary thyroid carcinomas (Fukushima et al., 2003; Kimura et al., 2003) and 5-20% colorectal carcinomas Yuen et al., 2002) . A total of 90% of all B-Raf mutations are a result of a single-base substitution that converts T to A at nucleotide 1799 (T1799A), producing a glutamic acid codon at amino-acid residue 600 in place of valine (V600E) in exon 15 . Mutation of this residue substantially increases the basal kinase activity of B-Raf, resulting in hyperactivation of ERK Satyamoorthy et al., 2003) . Not surprisingly, ectopic expression of constitutively active B-Raf V600E was shown to transform NIH 3T3 fibroblasts and immortalized mouse melanocytes Wellbrock et al., 2004) . Likewise, inhibition or knockdown of B-Raf V600E by RNA interference blocks melanoma cell proliferation and results in a partial induction of apoptosis (Hingorani et al., 2003; Karasarides et al., 2004; Hoeflich et al., 2006) . Collectively, these data implicate an oncogenic role for B-Raf in melanoma and other cancers that harbor constitutively active B-Raf mutations.
The spindle assembly checkpoint delays the onset of anaphase until all duplicated chromosomes are attached and aligned at the metaphase spindle. Activation of the spindle checkpoint involves kinetochore localization of several checkpoint proteins, including MAD1, MAD2, Bub1, BubR1, Bub3 and monopolar spindle 1 (Mps1). This leads to a complex consisting of MAD2, BubR1, Bub3 and Cdc20 (Cleveland et al., 2003; Kops et al., 2005 ) that prevents Cdc20 from activating the anaphasepromoting complex (APC)-an E3 ubiquitin protein ligase that triggers degradation of several mitotic regulators (Peters, 2002) . Recent evidence shows that Mps1 is a target of ERK in mitotic Xenopus egg extracts activated for the spindle assembly checkpoint arrest by nocodazole (Zhao and Chen, 2006) . Here, we report that oncogenic B-Raf V600E associates with the spindle checkpoint regulator Mps1 and promotes its hyperphosphorylation and stabilization in an ERK-dependent manner. As a consequence of elevated Mps1 levels in melanoma cells, the spindle checkpoint is hyperactivated causing a delay in mitotic progression.
Results

Ectopic B-Raf
V600E expression induces Mps1 levels in melanoma cell lines ERK activity is critical for maintenance of the spindle assembly checkpoint arrest (Takenaka et al., 1997; Wang et al., 1997) . Mps1, a key activator of the spindle checkpoint, was recently shown to be phosphorylated by ERK in Xenopus egg extracts treated with nocodazole (Zhao and Chen, 2006 (Figure 1a , left panel). In contrast, Bub1 protein levels remained the same following ectopic B-Raf V600E expression in SK-MEL5 cells. Mps1 and MAD1 levels increased similarly in the Sbcl2 melanoma cell lines transduced with a retroviral vector containing B-Raf V600E but not empty vector alone ( Figure 1a , right panel). Since MAD1 is implicated downstream of Mps1 (Hardwick et al., 1996; Abrieu et al., 2001) , we focused the rest of our studies on Mps1 regulation by B-Raf V600E .
To determine whether the increase in Mps1 levels was specifically due to the expression of the oncogenic form of B-Raf (B-Raf V600E ) or a consequence of overexpression of B-Raf protein per se, we transfected increasing amounts of GST-B-Raf WT or -B-Raf V600E plasmid DNAs into SK-MEL5 cells. These plasmid constructs generate GST fused to the N terminus of human full-length B-Raf proteins, which are readily distinguished from endogenous B-Raf by western analysis. Overexpression of B-Raf WT had little effect on Mps1 levels in SK-MEL5 cells, whereas increasing the amount of B-Raf V600E plasmid DNA for transfection lead to the induction of Mps1 protein levels (Figure 1b) (Figure 2 ). Thus, our data indicate that the induction of Mps1 levels by B-Raf V600E is regulated at the posttranscriptional level.
Analysis of Mps1 and B-Raf interactions in human melanoma cells
We tested whether B-Raf might associate with Mps1 in melanoma cells. To do this, SK-MEL5 cells were transfected with GST fusion full-length B-Raf WT or B-Raf V600E mutant expression plasmids and subjected to co-immunoprecipitation (IP) assays using antibodies to either Mps1 or B-Raf. The results show that GST-B-Raf and, to a lesser extent, endogenous B-Raf co-precipitated with Mps1 IP complexes (Figure 3a , right panel). Likewise, Mps1 protein co-precipitated with B-Raf IP complexes using a polyclonal anti-B-Raf antibody ( Figure 3a , left panel). Furthermore, in the absence of any recombinant protein expression, the association of endogenous B-Raf and Mps1 was readily detected in several melanoma cell lines (Figure 3b ). These results were specific since neither B-Raf nor Mps1 were detected in mock IPs using immunoglobulin G (IgG). Thus, we can conclude that B-Raf (B-Raf wt and B-Raf V600E ) and hMps1 associate (directly or indirectly) in vivo in a complex.
From the co-IP results, we predicted that some fraction of B-Raf and Mps1 might be co-localized at the subcellular level. Mps1 protein localizes to the kinetochores during the early stages of mitosis (Stucke et al., 2002; Liu et al., 2003) . Similarly, we recently showed that a fraction of phosphorylated B-Raf (Thr599/Ser602) in the cell also localizes to kinetochore regions during prometaphase and metaphase in human fibroblasts (Borysova et al., manuscript resubmitted). To determine whether Mps1 and B-Raf co-localize with each other, immunofluorescence studies with Mps1 and phospho-B-Raf (Thr599/Ser602) antibodies were performed in A375 melanoma cells. The results show that Mps1 and phospho-B-Raf (Thr599/Ser602) antibodies gave similar staining patterns in a prometaphase cell (Figure 3c , top panels). In fact, the overlay of both fluorescence patterns indicates strong co-localization at areas in yellow. Staining of kinetochores with CREST serum further shows that Mps1 and phospho-B-Raf (Thr599/Ser602) co-localize at the inner regions of kinetochores ( Figure 3c , see overlay middle and bottom panels). Taken together, our results suggest that Mps1 and B-Raf are associated with each other in vivo at the inner kinetochores during early stages of mitosis.
B-Raf
V600E signaling through ERK is critical for Mps1 expression We determined whether B-Raf expression was necessary for maintaining Mps1 steady-state levels in melanoma cells. Two distinct short interfering RNA pools (siRNA1 and 2) were used to reduce B-Raf expression in SK-MEL5 melanoma cells. Transfection of either B-Raf siRNA pool led to a substantial reduction (B90%) in B-Raf protein levels by 48-72 h, whereas a scrambled siRNA pool (SCR) had little effect compared to nontreated (ctrl) cells (Figure 4a ). Paralleling the reduction in B-Raf, Mps1 steady-state levels decreased markedly in SK-MEL5, and other melanoma cell lines were examined (Figures 4a and b ). This suggests that B-Raf is important for regulating Mps1 protein levels.
To determine whether MAPK activity via B-Raf signaling is critical for regulating Mps1 protein levels, we added the specific MEK inhibitor U0126 to 
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Y Cui and TM Guadagno SK-MEL5 cells that were transfected with a B-Raf V600E -containing plasmid. This led to a dramatic reduction of phospho-ERK levels ( Figure 4c ). Importantly, after 4 h of treatment with the MEK inhibitor, Mps1 protein levels were markedly reduced in both nontreated and B-Raf V600E -transfected SK-MEL5 cells (Figures 4c and d) . Together, these results suggest that B-Raf V600E signaling upregulates Mps1 levels in an ERK-dependant manner.
B-Raf
V600E expression upregulates Mps1 activity Next, we assessed whether elevated levels of Mps1 protein result in higher overall Mps1 activity following B-Raf V600E ectopic expression. Western analysis confirmed a threefold induction of Mps1 protein levels in transfected SK-MEL5 cells that transiently expressed GST-B-Raf V600E ( Figure 5a ). Mps1 IP complexes were isolated from equal amount of cell lysate-prepared SK-MEL5 cells transfected with plasmids containing GST alone, GST-B-Raf WT or GST-B-Raf
V600E
. Using myelin basic protein (MBP) as substrate of Mps1, the IP complexes were subjected to an in vitro kinase assay in the presence of g-32 P as previously described (Stucke et al., 2002) . Mps1-associated MBP kinase activity was undetectable in a mock IP using IgG and low in SK-MEL5 cells transfected with GST vector or GST-BRaf WT . In contrast, Mps1-associated MBP kinase activity was consistently higher (B10-fold) in SK-MEL5 cells transfected with GST-B-Raf V600E mutant compared to cells transfected with GST vector alone (Figures 5b and c) . To rule out the possibility that the majority of MBP phosphorylation was due indirectly to a protein kinase that co-precipitated with Mps1, green fluorescent protein (GFP)-tagged WT (Mps1-WT) or kinase-dead (Mps1-KD) Mps1 proteins were expressed in SK-MEL5 cells together with B-Raf
. Recombinant Mps1-WT and -KD proteins were immunoprecipitated from equal amounts of cell lysate using a GFP antibody, and IP complexes were subjected to an in vitro kinase assay as described above. The results showed that WT, but not KD, Mps1 complexes efficiently phosphorylated MBP under in vitro conditions (Figure 5d ), suggesting that the phosphorylation of MBP reflects the kinase activity associated with Mps1.
B-Raf
V600E signaling mediates phosphorylation of Mps1 through ERK The threefold increase in Mps1 protein levels accounts, in part, for the ten-fold higher kinase activity detected in melanoma cells that express constitutively active BRaf V600E . It is possible that post-translational mechanisms, such as phosphorylation, may also contribute to regulating Mps1 activity. Previous reports showed that Mps1 is modified by phosphorylation at mitosis corresponding to its peak in activity (Stucke et al., 2002; Liu et al., 2003; Zhao and Chen, 2006) . Therefore, we asked whether B-Raf V600E signaling regulated phosphorylation of Mps1. To test this, lysates from B-Raf V600E -transfected SK-MEL5 cells were separated through a 6% sodium dodecyl sulfate (SDS)-polyacrylamide gel and analysed by western blot to assess for any changes in the electrophoretic mobility of Mps1. Notably, the electrophoretic mobility of Mps1 was shifted up in SK-MEL5 cells that expressed the constitutively active B-Raf V600E mutant compared to mock, GST and B-Raf WT transfected cells (Figure 6a ). l-phosphatase treatment of Mps1 IP complexes abolished the electrophoretic mobility shift of Mps1 (Figure 6b ), demonstrating that its mobility shift stems from phosphorylation. Next, we asked whether the phosphorylation of Mps1 occurred in an ERK-dependent manner. ERK activity in SK-MEL5 cells was inhibited by the addition of U0126. The inhibition 
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In budding yeasts, Mps1 protein levels peaks during mitosis and then is degraded at anaphase by APC (Nasmyth, 2002; Palframan et al., 2006) . Thereafter, Mps1 remains unstable throughout the duration of interphase. Similar cell cycle regulation of Mps1 levels has been reported in HeLa cells (Stucke et al. 2002) . As such, Mps1 staining in SK-MEL5 (B-Raf WT ) cells is restricted to mitotic cells and undetectable in interphase cells (Figure 7c ). In contrast, Mps1 staining of A375 cells, which possess the B-Raf V600E mutation, showed Mps1 present in both interphase (yellow arrows) and mitotic (red arrows) cells. In fact, about 70% of A375 cells in interphase stained positive with an Mps1 antibody, whereas none of the interphase SK-MEL5 cells were positive for Mps1 (Figure 7d) . Hence, we conclude that high levels of Mps1 remain present throughout the cell cycle due to its stabilization by constitutive B-Raf V600E signaling.
Oncogenic B-Raf V600E signaling promotes an M-phase cell cycle delay Next, we investigated the effects of constitutive BRaf V600E signaling on the cell cycle. Sbcl2 melanoma cells were transduced with pBabe-B-Raf V600E or pBabe-puro retroviruses and assessed for changes in cell cycle distribution by fluorescence-activated cell sorting (FACS) analysis of DNA content. Western analysis confirmed that phospho-ERK and Mps1 levels increased in Sbcl2 cells that were infected with pBabe-BRaf V600E retrovirus compared to pBabe-puro alone (Figure 8a) . Interestingly, FACS analysis of DNA content showed that ectopic B-Raf V600E expression led to a three-to fourfold increase in G 2 /M DNA content (6.1 vs 21.5%) with decreases in G 1 (67.96 vs 57.57%) and S phases (25.83 vs 20.90%; Figure 8b ). Phosphorylation of histone H3 at residue Ser-10, a marker for mitosis, was assessed by immunostaining with a phospho-H3 (Ser10) ) cells stained positive for phospho-H3 compared to control (pBabepuro) Sbcl2 cells (Figures 8c and d) . Closer inspection showed that B-Raf V600E expression caused Sbcl2 cells to accumulate in prometaphase/metaphase compared to control Sbcl2 cells (Figure 8d ). Moreover, a dramatic decrease in anaphase/telophase (white bar) was observed, suggesting that ectopic B-Raf V600E expression in Figure 8 Ectopic B-Raf V600E expression causes a mitotic delay through Mps1. Sbcl2 melanoma cells were infected with retroviruses to allow for ectopic expression of B-Raf V600E alone or in combination with an Mps1 siRNA (pSUPER-retro-Mps1). Empty vectors, pBabe or pSUPER-retro, were used as controls. Transduced Sbcl2 cells were selected up to 10 days in 0.8 mg ml À1 puromycin and subjected to 
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To determine whether the cell cycle delay at mitosis induced by B-Raf V600E expression was mediated through Mps1, parallel Sbcl2 cultures were co-transduced with pBabe-B-Raf V600E and pSUPER-retro-Mps1 (siRNA vector) retroviruses to selectively knock down Mps1 protein levels by RNAi. As shown in Figure 8a, Mps1 Oncogenic B-Raf deregulates Mps1 Y Cui and TM Guadagno protein was substantially reduced by pSUPERretro-Mps1. As a result of depleting Mps1, the mitotic delay induced by constitutively active B-Raf V600E was suppressed as supported by FACS analysis, phospho-H3 staining and immunofluorescence microscopy (Figures 8b-d) . Thus, we conclude that Mps1 is important for mediating the mitotic delay brought about by oncogenic B-Raf V600E .
Oncogenic B-Raf V600E signaling prolongs spindle checkpoint activation Mps1 mediates activation of the spindle checkpoint through its ability to recruit spindle checkpoint proteins MAD1 and MAD2 to unattached kinetochores (Abrieu et al., 2001) . We asked whether elevated levels of Mps1 activity mediated by B-Raf V600E expression might deregulate activation of the spindle checkpoint. To test this possibility, Sbcl2 cells were infected with pBabe-puro, pBabe-B-Raf V600E or pBabe-B-Raf V600E and pSUPERMps1 retroviruses. In Sbcl2 cells infected with pBabe-B-Raf V600E retrovirus alone, the expression of spindle checkpoint proteins Mps1, MAD1 and MAD2 increased while the levels of Bub1 and kinetochoreassociated protein CENP-E remained the same (Figure 9a ). Immunostaining of MAD1 and MAD2 at the kinetochores, an indicator of spindle checkpoint activation, was detected in 2-3 times as many Sbcl2 cells expressing constitutively active B-Raf V600E compared to control Sbcl2 (pBabe-puro) cells. This is consistent with our results in Figure 8 showing a threefold increase in M-phase cells following B-Raf V600E expression. Furthermore, the intensity of MAD1 and MAD2 staining at the kinetochores was twofold higher in pBabe-B-Raf V600E -infected Sbcl2 cells compared to Sbcl2 cells infected with pBabe-puro retrovirus (Figure 9b) . Results representative of these observations are presented in Figures 9c and  d (compare middle and top rows) . A modest increase of Bub1 staining at the kinetochores was also observed, whereas no difference was seen for CENP-E (Figure 9b ). In the absence of Mps1 expression, the localization of MAD1 and MAD2 proteins to the kinetochores was completely blocked in Sbcl2 cells that ectopically expressed constitutively active B-Raf V600E (Figures 9b-d , see bottom panels of c and d). Similarly, we found that the localization of CENP-E to the kinetochores was also dependent on the presence of Mps1 (Figure 9b ; Supplementary Figure S1 ), confirming previous results in Xenopus egg extracts (Abrieu et al., 2001) . In contrast, localization of Bub1 at the kinetochores was not dependent on the presence of Mps1 as previously shown (Liu et al., 2003) . Collectively, our results suggest that BRaf V600E signaling prolongs activation of the spindle checkpoint in an Mps1-dependent manner.
Discussion
To date, studies have been focused on the effects of the B-Raf V600E mutant in disrupting melanoma cell proliferation during G 1 and G 1 /S phases (Calipel et al., 2003; Conner et al., 2003; Bhatt et al., 2005) . Our studies reveal that oncogenic B-Raf V600E signaling deregulates the spindle checkpoint pathway during mitosis as a consequence of sustaining high levels of Mps1 activity in melanoma cells. We propose that deregulation of spindle checkpoint pathway by oncogenic B-Raf V600E signaling may make melanoma cells prone to errors in chromosome segregation.
One of the key findings of this study was showing an in vivo association between B-Raf and Mps1 (Figures 3a  and b) and, their co-localization at the kinetochores during prometaphase/metaphase (Figure 3c ). How the two proteins associate with each other and whether this association is direct or indirect remains to be elucidated in future studies. MEK and ERK, but not C-Raf, were also found associated in Mps1 IP complexes (Supplementary Figure S2 ), indicating that B-Raf signals through the ERK cascade to regulate Mps1. In fact, we showed that MEK activity was required for the induction of Mps1 levels by oncogenic B-Raf V600E ( Figure 4c ) and the hyperphosphorylation of Mps1 (Figure 6c ). We also assessed whether Mps1/B-Raf complexes might associate with Raf kinase inhibitory protein (RKIP) in view of a recent report showing its localization at kinetochores and role in regulating Aurora B and the spindle checkpoint (Eves et al., 2006) . Mps1 complexes isolated from SK-MEL5 and A375 were unable to detect RKIP (Supplementary Figure S2) . Moreover, overexpression of active BRaf V600E did not effect RKIP localization at the centrosomes or kinetochores (Supplementary Figure  S3) . Owing to RKIP's low expression in melanoma cells (Park et al., 2005) , we speculate that oncogenic BRaf V600E would override its potential inhibitory role in regulating ERK activity at the mitotic spindle.
How B-Raf V600E signaling mediates stabilization of Mps1 in melanoma cells will be an area to investigate in future studies. Our results indicate that phosphorylation may play a role in regulating Mps1 stabilization. This is based on the observation that Mps1 induction by B-Raf V600E signaling correlates with its hyperphosphorylation ( Figure 6 ). Likewise, knockdown of B-Raf or the inhibition of ERK results in a precipitous drop in Mps1 levels ( Figure 4 ) and an increase in its electrophoretic mobility on a 6% SDS protein gel (Figure 6c ). Human Mps1 contains eight T/SP motifs that are potentially targeted for phosphorylation by a proline-directed kinase, such as ERK or Cdk1. Studies in budding yeast show that Mps1 levels are maintained at the spindle pole body during the G 1 /S phase by Cdc28 (Cdk1) phosphorylation at residue Thr29 of Mps1 (Jaspersen et al., 2004) . In mouse cells, Cdk2 activity was found important for Mps1 stability at the centrosome during G 1 /S (Fisk and Winey, 2001 ). It will be important to identify which sites on Mps1 are phosphorylated by B-Raf V600E signaling in order to begin elucidating the mechanisms associated with its stabilization.
Defects in spindle checkpoint control contribute to loss or gain of chromosomes (aneuploidy) in many human cancers by allowing for errors in chromosome segregation (Jallepalli and Lengauer, 2001; Bharadwaj and Yu, 2004) . Aneuploidy and chromosome instability are common features in human cutaneous melanomas (Bastian et al., 1998; Curtin et al., 2005) but the molecular events that mediate these chromosome abnormalities are poorly understood. We propose that sustained activation of the spindle checkpoint, mediated by B-Raf V600E -induction of Mps1 levels in melanoma, may be a contributing factor that compromises the fidelity of chromosome segregation. Equally plausible is the possibility that high Mps1 levels may produce centrosome reduplication as reported in S phasearrested mouse NIH 3T3 cells Mps1 (Fisk and Winey, 2001) , which would lead errors in chromosome segregation. Studies to examine these two possibilities are currently in progress. Interestingly, expression of oncogenic Ras in PCCL3 thyroid cells is also linked to mitotic spindle checkpoint defects (Knauf et al., 2006) . In contrast to our results, oncogenic Ras signaling in PCCL3 thyroid cells bypassed the spindle checkpoint arrest independent of MAPK activation. These results suggest that other Ras effectors may be involved, which could account for the differences between oncogenic Ras and B-Raf V600E on the spindle checkpoint. In summary, our results identify Mps1 as a new target deregulated by oncogenic B-Raf V600E signaling, which prolongs activation of the spindle checkpoint. These findings, as they relate to deregulation of the spindle checkpoint pathway, reveal a new mechanism through which B-Raf V600E signaling may exert its oncogenic effects in melanoma.
Materials and methods
DNA plasmid constructs and siRNAs pEBG DNA plasmids, containing an N-terminal GST tag fused to full-length human B-Raf WT or B-Raf V600E , were generously provided by Dr JM Kyriakis as described (Chadee and Kyriakis, 2004) . pBabe-puro, pBabe-puro-B-Raf V600E retroviral vectors and pooled B-Raf siRNA reagents were generous gifts from Dr DS Peeper (The Netherlands Cancer Institute). Retroviral vectors, pBabe-puro or pBabe-BRaf V600E , were transfected into HEK293T replication-defective packaging cells for retroviral production. For experiments to selectively knock down Mps1, an siRNA sequence of human Mps1 corresponding to nucleotides 133-155 (GeneBank accession number NP_003309) was cloned into the pSUPERpuro retroviral vector and transfected into the replicationdefective packaging cell line LA for retrovirus production (pSUPER-puro vector and LA packaging cells generously provided by Dr Jiandong Cheng-H Lee Moffitt Cancer Center).
Melanoma cell lines and maintenance SK-MEL5, SK-MEL28, A375 melanoma cells were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA). WM35 and Sbcl2 cells were obtained from M Herlyn (Wistar Institute, Philadelphia, PA, USA) and are both WT for B-Raf (Satyamoorthy et al., 2003) . SK-MEL5 cells are WT for B-Raf, while SK-MEL28 and A375 cells carry BRaf V600E mutations Satyamoorthy et al., 2003) . Melanoma cells (except for WM35 and Sbcl2) were grown in Dulbecco's modified Eagle's medium (Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS). WM35 and Sbcl2 cells were grown in 2% tumor media (4:1 mix of MCDB153/L15 media, 2% FBS, 5 mg ml À1 insulin, 1 mM CaCl 2 ). Melanoma cells were maintained at 37 1C in a humidified chamber containing 5% CO 2 . In some experiments the MEK1/2 specific inhibitor U0126 (Promega, Madison, WI, USA) was added to cell cultures (10-20 mM final) to block ERK activation. Cell cycle distribution (G 1 , S and G 2 /M phases) was monitored by FACS analysis of DNA content (performed by flow cytometry facility of Moffitt Cancer Center).
Cell transfections and retroviral infections
Transfections for transient gene expression in SK-MEL5 cells were performed by standard calcium phosphate precipitation. Co-transfection with a GFP-containing plasmid estimated transfection efficiency at 40-50%. Sbcl2 cells were infected with pBabe-puro, pBabe-B-Raf V600E , pSUPER-puro or pSU-PER-siMps1 retroviruses as described (Peeper et al., 2002 ) and were selected in puromycin (0.8 mg ml À1 ) for up to 10 days. Drug-resistant colonies were pooled and checked for ectopic B-Raf V600E expression or reduction of hMps1 protein by immunoblot analysis. For knockdown of B-Raf expression, an siRNA pool (100 pmol) was introduced into 1 Â 10 6 cells via nucleofection with an Amaxa Nucleofector (Amaxa Inc., Gaithersburg, MD, USA) using Solution R/program K-17 as described (Stahl et al., 2004) .
Preparation of cell lysates and immunoblotting analysis
Adherent melanoma cells, washed with cold 1 Â phosphatebuffered saline, were scraped into cell lysis buffer (50 mM TrisHCl, pH 7.5, 150 mM NaCl, 5 mM ethylene glycol tetraacetic acid, 0.5% NP-40) containing protease and phosphatase inhibitors (1 mM phenylmethylsulphonylfluoride, 10 mg ml À1 aprotinin, 10 mg ml À1 leupeptin, 25 mM NaF, 1 mM sodium vanadate), and centrifuged at 14000 r.p.m. for 15 min at 4 1C to pellet insoluble cell debris. Protein concentrations of supernatants were determined using the Dc protein assay (Bio-Rad, Hercules, CA, USA). Equal amounts of protein were resolved by 10% SDS-polyacrylamide gel electrophoresis (PAGE), electrophoretically transferred to polyvinylidene fluoride membranes (Millipore Corporation, Billerica, MA, USA), and subjected to immunoblot analysis. To assess phosphorylation of Mps1 protein, protein samples were separated on 6% SDS-polyacrylamide gels. Primary antibodies used include: rabbit b-actin, rabbit anti-B-Raf (H-145), rabbit antiphospho-B-Raf (Thr599/Ser602), MAD1 monoclonal, MAD2 monoclonal, Bub1 monoclonal and anti-CENP-E (H-130) antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA); mouse monoclonal (N1) hMps1 (Abcam, Cambridge, MA, USA); phospho-p44/42 MAPK (Thr202/tyr204; E10) monoclonal and phospho-H3 (Ser10) antibodies (Cell Signaling, Beverly, MA, USA); mouse anti-ERK1, anti-human 14-3-3 and mouse anti-CAS antibodies (BD Transduction Laboratories, San Diego, CA, USA). Secondary antibodies, alkaline phosphatase-conjugated AffiniPure Goat anti-Mouse IgG or anti-Rabbit IgG-alkaline phosphatase antibody (Sigma, St Louis, MO, USA), were incubated for 1 h at room temperature and then processed for chemiluminescence detection using the CDP-Star reagent (Roche, Indianapolis, IN, USA).
Abbreviations APC, anaphase-promoting complex; CHX, cycloheximide; ERK, extracellular signal-regulated kinase; IP, immunoprecipitation; Mps1, monopolar spindle 1; SCR, scrambled siRNA; siRNA, short interfering RNA; WB, western blot; WT, wild type.
